•
COVID‐19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated.
https://poal.co/s/CoronaVirus/413634
http://web.archive.org/web/20210808233038/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/
COVID‐19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated.
https://poal.co/s/CoronaVirus/413634
http://web.archive.org/web/20210808233038/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/
(post is archived)